Psychotropic Drugs Reemerging as Headache Medicines
CNS Drugs · 2024
DOI: 10.1007/s40263-024-01107-x ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Drugs, 2024. Verfasst von Emmanuelle A D Schindler. Beteiligte Einrichtung: Neurology Service, VA Connecticut Healthcare System, MS 127, 950 Campbell Avenue, West Haven, CT, 06516, USA. emmanuelle.schindler@yale.edu. Hauptthemen laut MEDLINE: Headache Disorders, Pain Management, Psychotropic Drugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Scientific and public attention on the therapeutic effects of psychedelics and other psychoactive compounds in headache disorders has recently grown. The use and reported therapeutic effects of such treatments have long been reported, though formal clinical trials are only recently taking place. When considering how these substances might be further studied and eventually applied, it is important to consider the specific headache disorder, the particular drug, and the mode of use. No singular protocol will be applicable across all headache disorders and drugs. In this leading article, the nuance required to consider the value of classic psychedelics, ketamine, and cannabinoids as headache medicines is presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neurology Service, VA Connecticut Healthcare System, MS 127, 950 Campbell Avenue, West Haven, CT, 06516, USA. emmanuelle.schindler@yale.edu.
- Department of Neurology, Yale School of Medicine, New Haven, CT, USA. emmanuelle.schindler@yale.edu.
ORCID-Profile: Emmanuelle A D Schindler
Zitieren
APA
Schindler, E. A. D. (2024). Psychotropic Drugs Reemerging as Headache Medicines. CNS Drugs. https://doi.org/10.1007/s40263-024-01107-x
Vancouver
Schindler EAD. Psychotropic Drugs Reemerging as Headache Medicines. CNS Drugs. 2024. doi:10.1007/s40263-024-01107-x
BibTeX
@article{Schindler2024,
author = {Schindler, Emmanuelle A D},
title = {Psychotropic Drugs Reemerging as Headache Medicines},
journal = {CNS Drugs},
year = {2024},
doi = {10.1007/s40263-024-01107-x}
}
EUVIMED